New treatment could increase lung cancer survival
Researchers are tackling the problem of chemoresistance in lung cancer patients with a new treatment, which offers hope of increased lung cancer survival rates.
May 16, 2023
0
17
Researchers are tackling the problem of chemoresistance in lung cancer patients with a new treatment, which offers hope of increased lung cancer survival rates.
May 16, 2023
0
17
Researchers from the Department of Molecular Biology and Genetics at Koc University in Turkey and the Pole of Endocrinology, Diabetology and Nutrition, Institute of Experimental and Clinical Research at Université Catholique ...
Colorectal cancer is the fourth most common and second deadliest cancer. How colorectal cancer develops is not well understood, but a team led by researchers at Baylor College of Medicine reports in the Journal of Experimental ...
May 10, 2023
0
7
Cachexia is a syndrome characterized by severe loss of weight and muscle mass. It is present in approximately half of all lung cancer patients and is particularly damaging in cases of non-small cell lung cancer. Early detection ...
May 10, 2023
0
9
Gastric cancer is the fifth most commonly diagnosed malignancy worldwide. It ranks a sad third in cancer-related causes of death. The reason for this is late diagnosis coupled with rapid spread of tumor cells in the body.
May 8, 2023
0
29
In recent years, the use of big data in health care has become more prevalent, and one area where it is proving particularly useful is in precision medicine. Precision medicine aims to provide more personalized health care ...
Apr 19, 2023
0
7
A large retrospective study conducted by physician researchers from Roswell Park Comprehensive Cancer Center reports benefits of chemotherapy for many patients with early-stage breast cancer with rare variant histology, or ...
Apr 18, 2023
0
2
A recent research effort led by Sarbajit Mukherjee, MD, MS, Assistant Professor of Oncology at Roswell Park Comprehensive Cancer Center, demonstrated that a new chemotherapy combination—trifluridine/tipiracil (FTD/TPI) ...
Apr 18, 2023
0
1
Indiana University Melvin and Bren Simon Comprehensive Cancer Center served as the lead site for a promising first-in-human clinical trial for patients with relapsed multiple myeloma. Patients treated with higher doses of ...
Apr 17, 2023
0
2
A new research perspective was published in Oncotarget entitled "Cancer prevention with rapamycin."
Apr 17, 2023
0
1